- Systematic review and meta-analysis of 11 randomized controlled trials (n = 810) testing exercise for pregnancy-related pelvic girdle pain.
- The review explored how exercise prescription parameters, such as supervision and core-focused programs, related to pain and function outcomes.
- Exercise significantly reduced pain (SMD -0.81; 95% CI -1.06 to -0.55) and improved function (SMD -0.69; 95% CI -1.01 to -0.37), with moderate certainty.
- Limited subgroup data suggested supervised abdominopelvic core exercise may have larger effects, but these findings had substantial heterogeneity and very low to moderate certainty.
Latest papers
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- This systematic review and meta-analysis pooled 21 studies (3 randomized trials) with 605 ketamine-treated CRPS patients, mostly at moderate to high risk of bias.
- Pain change was pooled from the earliest post-infusion assessment within 14 days, with scores rescaled to 0-10 against a pooled baseline of 7.4.
- The mean pain change was -3.6 (95% CI -4.7 to -2.5) within 14 days, and longer-term data up to 90 days suggested a gradual return toward baseline.
- Median responder rate was 65% (range 0-100%), but only 3 studies formally assessed predictors; sympathetically maintained pain (aOR 6.54) and obesity (aOR 8.75) had wide CIs.
- Systematic review and multivariate meta-analysis of 118 studies (N = 11,822) comparing adults with fibromyalgia, knee osteoarthritis, low back pain, or neck pain against pain-free controls.
- Case-control differences were pooled as Hedges' g across five domains: brain, sensory, psychological, motor, and tissue measures.
- Psychological (g = 1.08, 95% CI 0.94-1.22) and sensory (g = 0.85, 95% CI 0.61-1.08) differences were larger than motor, brain, and tissue differences, with tissue smallest (g = 0.30, 95% CI 0.05-0.55).
- Effect patterns differed by diagnosis, with fibromyalgia showing larger differences across domains; the authors suggest multidomain assessment may help distinguish pain states.
- A systematic review of 20 studies across eight databases, following PRISMA, examined acute postoperative pain tools in adults aged 18 and older.
- The review identified 17 tools: 12 behavioral observation measures and 5 combining behavioral and physiological indicators, rated with COSMIN standards.
- Measurement properties were often underreported, particularly content validity, structural validity, and reliability, and many studies had a high risk of bias.
- The authors highlight the Acute Pain Assessment 5, Critical-Care Pain Observation Tool, and Multidimensional Objective Pain Assessment Tool as promising, while noting their limitations.
- A systematic review of 39 studies examined how different surgical procedures change disability measured by the WHODAS 2.0 questionnaire.
- Pre-operative disability ranged from 2% to 61%, and in 21 studies disability rose by 1% to 17% within 3 months of surgery.
- Orthopaedic studies reported 10-37% reductions in disability within 3 months, while cancer surgery studies reported small 1-8% increases.
- The authors found 13 different endpoints and three disability thresholds across studies, and called for standardised reporting of disability outcomes.
- Meta-analysis of 35 randomized trials with 3831 patients comparing intraoperative low-dose IV esketamine (<1 mg/kg) with control for acute postoperative pain.
- Esketamine was compared with control, with outcomes including resting and movement pain, opioid use, rescue analgesia, and adverse events.
- Resting pain was lower at 4 h (MD -1.40, p<0.0001) through 48 h, movement pain at 12 to 48 h, and rescue analgesia was reduced (RR 0.52, p=0.0001).
- Authors describe a modest pain reduction with no significant adverse event difference, but note heterogeneity and limited evidence make the magnitude and consistency uncertain.
- Systematic review and meta-analysis of eight randomized trials (12,669 patients) comparing aggressive and conservative blood pressure lowering in acute intracerebral hemorrhage.
- Excellent functional outcome did not differ (RR 1.07; 95% CI 0.99-1.16), nor did 90-day mortality (RR 0.90; 95% CI 0.77-1.05) or hematoma growth.
- Aggressive lowering was associated with fewer adverse events (RR 0.87; 95% CI 0.76-0.99; p = 0.03), though overall heterogeneity was substantial (I2 = 59%).
- Sensitivity analyses showed a small good-recovery benefit (RR 1.05; 95% CI 1.01-1.10) that the subgroup analyses did not confirm.
- Systematic review and meta-analysis of 12 RCTs including 713 adult cardiac surgery patients undergoing cardiopulmonary bypass.
- Compared intraoperative haemoadsorption inserted into the bypass circuit with conventional bypass without haemoadsorption.
- No significant mortality benefit was found (OR 1.08, 95% CI 0.59-2.01, P=0.75), and no significant difference in hospital or ICU length of stay.
- Authors conclude there was no evidence of clinical benefit for routine use, but clinically relevant benefit or harm cannot be excluded, and only one included study had low risk of bias.
- This systematic review screened ERAS Society guidelines, including 24 guidelines from 39 publications dated 2013 to 2025, for anaesthesiological recommendations.
- Each guideline's anaesthesiological recommendations were classified across 45 umbrella terms by consistency of recommendation across guidelines, with AGREE II used to rate methodological quality.
- Eight terms were consistent, including multimodal analgesia, fasting, and thromboprophylaxis, while 16 were mixed and 11 were sparse; mean AGREE II score was 76%.
- The authors argue a consistent anaesthesiological core exists, and flag mixed-strength, high-frequency domains such as fluid management for structured local appraisal.
- This systematic review and meta-analysis pooled 16 retrospective studies of 3,121 durable LVAD insertions, with risk of bias assessed using the Newcastle-Ottawa Scale.
- Vasoplegic syndrome was studied in LVAD insertions performed via cardiopulmonary bypass, with a pooled incidence of 36.30% (95% CI 34.61%-38.02%).
- Reported risk factors included male sex (RR 1.65, p = 0.008), INTERMACS profile ≤2 (RR 1.19, p = 0.009), repeat sternotomy, concomitant procedures, and longer bypass time (WMD 13.17 minutes).
- Vasoplegic syndrome was associated with more right ventricular failure, renal replacement therapy, bleeding reoperation, and higher 30-day mortality (14.85% vs 5.63%, p < 0.001).
- Systematic review and network meta-analysis of 158 randomised trials with 18,794 participants comparing regional anaesthesia with no block for chronic postsurgical pain.
- Analyses compared regional anaesthesia with no block and examined technique, timing and catheter versus single-injection delivery across surgery types.
- Regional anaesthesia reduced chronic postsurgical pain incidence (RR 0.73, 95% CI 0.67-0.80), with effects reported up to 12 months, while opioid use did not differ significantly (RR 0.88, 95% CI 0.61-1.28).
- Neuraxial techniques appeared more effective than peripheral techniques after thoracotomy and video-assisted thoracoscopic surgery, but certainty was low to very low, and surgery type, sex and baseline risk had no significant effect.
- This NATA consensus document combines a systematic review of evidence on intravenous iron safety with expert recommendations.
- It covers intravenous iron for iron deficiency and iron-deficiency anaemia, focusing on adverse events rather than comparing specific treatments.
- Adverse events addressed include hypersensitivity and infusion reactions, hypophosphataemia, extravasation, and potential infection risk.
- The authors offer practical guidance on diagnosing adverse events, mitigating risk, counselling patients, and selecting formulations.
- Systematic review and meta-analysis of 23 randomized trials (2,028 participants) in chronic or postoperative musculoskeletal pain.
- Melatonin was compared with placebo and with active controls such as analgesics.
- In chronic pain, melatonin did not beat placebo overall (MD -6.76/100, 95% CI -15.89 to 2.36), but a low-risk sensitivity analysis did (MD -10.04, 95% CI -17.68 to -2.39).
- The authors call the benefits modest, with most estimates below minimal clinically important difference thresholds and low-to-moderate certainty evidence.
- Systematic review and meta-analysis of 38 randomized trials enrolling 5,424 adults undergoing surgery.
- Compared systemic perioperative selective COX-2 inhibitors with placebo, opioids, or usual care, using multidimensional pain instruments such as the Brief Pain Inventory.
- Acute pain interference was lower with COX-2 inhibitors (Brief Pain Inventory MD -1.1; 95% CI -1.4 to -0.8; moderate certainty).
- Chronic pain incidence was lower (OR 0.44; 95% CI 0.21 to 0.93; low certainty), and the authors judged the acute benefit likely clinically meaningful.
- Preregistered PRISMA systematic review of 28 studies with 1142 participants, 59% of whom were women.
- Examined neurophysiological and psychophysical mechanisms of immersive VR-induced hypoalgesia, with 76% of participants exposed to experimentally induced pain.
- Synthesis linked IVR hypoalgesia to increased activity in descending pain modulation nuclei, enhanced parasympathetic activity, and higher pain tolerance or thresholds.
- Most studies (89.3%) assessed only immediate effects of a single session, and the authors call for causal designs, ideally mediation analyses.
- Qualitative systematic review of 34 ethics articles (commentaries, opinion pieces, academic articles) on slow codes in U.S. hospitals, drawn from 12,863 screened records.
- The exposure is the "slow code," in which clinicians appear to give advanced cardiac life support without fully committing to resuscitation.
- Of the 34 articles, 61.8% (n = 21) argued physicians should be allowed to refuse CPR in futile cases, 23.5% (n = 8) supported slow codes when families request full resuscitation, and 26.5% (n = 9) took nuanced positions.
- The authors conclude most ethics literature deems slow codes impermissible, while physicians remain divided in practice, and call for clearer communication and ethical guidance.
- Systematic review and meta-analysis of 20 randomised controlled trials including 1198 adults undergoing elective shoulder surgery.
- Compared continuous with single-injection brachial plexus blocks for postoperative analgesia, using patient-reported pain and related outcomes.
- Continuous blocks gave lower resting pain at 12, 24 and 48 h (MD -1.96, -1.66 and -1.18; all p < 0.001), but pain on movement was not significantly different at 24 h (MD -2.04, 95% CI -4.26 to 0.19) or 48 h.
- The authors conclude continuous blocks improve resting pain and other patient-centred outcomes, while dynamic pain and long-term function remain uncertain.
- Systematic review and Bayesian network meta-analysis of 13 studies, covering 54 models and 927,113 patients undergoing non-cardiac surgery.
- Machine learning models were compared with the Revised Cardiac Risk Index, analysing the best and worst version of each model type.
- Automated machine learning ranked highest (SUCRA 96.6; best-version MD 0.28, 95%CrI 0.16-0.40), and gradient boosting also outperformed the Revised Cardiac Risk Index (MD 0.20, 95%CrI 0.14-0.26).
- The authors conclude that most machine learning models discriminate better than traditional scores, but none were externally validated, only six had low risk of bias, and prospective multicentre evaluation is needed.
- Systematic review and meta-analysis of eight randomised trials with 471 patients comparing intrathecal morphine with peripheral regional analgesia in elective total hip arthroplasty.
- Peripheral regional analgesia was a peripheral nerve block in six trials and local infiltration analgesia in two.
- At 24 h, resting pain did not differ, while intravenous morphine equivalent use was lower with intrathecal morphine (MD 11.38 mg, 95% CI 4.31 to 18.45).
- Pruritus was more frequent with intrathecal morphine (0.31, 95% CI 0.17 to 0.58 for peripheral analgesia), and the authors rate this evidence as high quality.
- Systematic review and meta-analysis of 32 studies (27 meta-analyzed, 5 narrative) in hospitalized preterm and full-term newborns within their first month of life.
- The exposure of interest was acute skin-breaking painful procedures, with heart rate variability (HRV) patterns of pain-related stress reactivity and regulation as outcomes.
- The authors report four themes: effects of gestational and postnatal age, variability across HRV measures, normative regulation patterns, and heterogeneity across HRV outcomes. The abstract gives no pooled effect sizes or confidence intervals.
- Substantial heterogeneity and risk of bias across studies were major limitations, and the authors discuss methodological and clinical considerations for future research.
- Systematic review and six meta-analyses of 65 studies in adults comparing continuous non-invasive blood pressure devices with invasive arterial measurement.
- Devices tested were volume clamp (ClearSight, CNAP), applanation tonometry (T-Line, Vasotrac, N-CAT) and photoplethysmography, assessed against AAMI bias and SD criteria.
- Volume clamp devices met no AAMI bias or SD criteria, whereas only N-CAT met SD criteria for MAP, SBP and DBP (MAP SD 6.97 mmHg).
- The authors conclude that most devices did not meet AAMI criteria, limits of agreement were wide, and N-CAT shows promise.
- Systematic review and meta-analysis of 17 randomized controlled trials including 1871 children undergoing surgery, comparing music with no-music controls.
- Music was compared with no-music controls across preoperative anxiety, postoperative pain, heart rate, and blood pressure outcomes.
- Music significantly reduced preoperative anxiety (SMD -2.03, 95% CI -3.19 to -0.86) and postoperative pain (SMD -0.64, 95% CI -1.01 to -0.27).
- Heart rate and mean arterial pressure also fell (MD -12.92 bpm; MD -8.41 mmHg), with no significant effect on systolic pressure.
- Systematic review and meta-analysis of 20 studies including nearly 800,000 adult cardiac surgery patients.
- Compared ultra-fast-track extubation (in the OR or within 1 hour) with fast-track extubation (within 6 hours in the ICU).
- UFTE was linked to lower 30-day mortality (OR 0.54), shorter ICU stay (MD -12.27 hours) and shorter hospital stay (MD -1.19 days).
- In propensity-matched cohorts, mortality and reintubation were comparable, though shorter stays persisted, and the authors call for randomized trials.
- This systematic review and meta-analysis pooled 32 studies of 3142 patients, including six diagnostic, 22 prognostic, and four studies reporting both.
- Diagnostic studies were not pooled, but individual studies suggested sensitivity of 78-95% and specificity of 80-90% for detecting raised central venous and right atrial pressure.
- In cardiac patients, VExUS of at least 2 was associated with acute kidney injury (OR 4.44, 95% CI 2.34-8.43) and mortality (OR 3.17, 95% CI 1.30-7.75), while in critically ill patients no association was found for either outcome.
- The authors conclude VExUS has moderate to good accuracy for raised central venous and right atrial pressure, and that its link to outcomes is clearer in cardiac than in critically ill patients; per-patient VExUS 3 was associated with mortality across all patients.
- Systematic review and meta-analysis of 15 randomized trials (15,603 patients) comparing higher versus routine intraoperative blood pressure targets in adults undergoing elective noncardiac surgery under general anesthesia.
- Higher targets, either fixed absolute thresholds or personalized to preoperative baseline, were compared with routine blood pressure management.
- Higher targets did not reduce acute kidney injury (RR 0.95; 95% CI 0.85 to 1.06) or acute myocardial injury (RR 1.02; 95% CI 0.94 to 1.12), and mortality was unchanged (RR 1.00; 95% CI 0.75 to 1.34).
- A reduction in postoperative delirium was seen (RR 0.73; 95% CI 0.54 to 0.98), but trial sequential analysis judged this cumulative evidence insufficient, so the authors call for confirmation in adequately powered trials.
- Systematic review of 23 non-randomized studies of adults with chronic pain and trauma symptoms, drawn from over 12,000 screened records.
- Eligible studies tested psychological interventions aimed at both chronic pain and trauma-related symptoms at once.
- Five of eight pain-primary studies, three of seven trauma-primary studies, and six of eight dual-primary studies improved both pain and trauma outcomes.
- Authors concluded the most effective approach remains unclear due to heterogeneity, though psychotherapies may improve both pain and trauma; they call for standardized trial design.
- Systematic review of 23 clinical studies, plus a retrospective cohort of 215,474 adult ICU patients in Japan's multicenter claims database (2010–2021).
- The exposure was the varying PICS definitions extracted from the review, applied to the same cohort; no intervention was studied.
- Patient counts per definition ranged from 211 to 47,888, prevalence from 0.1% to 22.2%, and in-hospital mortality from 11.4% to 64.0%.
- Despite this heterogeneity, PICS consistently identified patients with prolonged hospital stay and physical impairment, and the authors call for standardized criteria.
- Systematic review of five studies including 1,196 adults receiving venoarterial ECMO, published 2000 to 2022, with patients grouped by BMI.
- Compared mortality between patients with BMI <30 and those with BMI ≥30, using a χ2 analysis across pooled studies.
- Mortality was 60.3% for BMI <30 and 58.6% for BMI ≥30 (p = 0.6), and four of five cohorts found no BMI-mortality association.
- The authors conclude obesity alone should not preclude VA-ECMO, but note the data are limited, heterogeneous, and call for caution.
- Systematic review and network meta-analysis of 24 randomised trials including 2,130 adults undergoing surgery with single-injection peripheral nerve blocks.
- Compared eight pharmacological prophylactic strategies against control for preventing rebound pain after nerve block.
- Intravenous dexamethasone had the highest probability of reducing rebound pain incidence (SUCRA 0.91) and was judged definitely superior to control.
- Perineural dexamethasone and dexmedetomidine ranked highest for delaying rebound pain, while certainty of evidence ranged from very low to moderate.
- Meta-analysis of 114 trials with 13,951 surgical patients, mostly low risk of bias, with nearly all HES administration limited to under 24 hours.
- Trials used HES 130/0.4 or 130/0.42 in surgical patients, with acute kidney injury and preoperative-to-postoperative creatinine change as the focus.
- HES did not significantly increase acute kidney injury (RR 1.02; 95% CI 0.91 to 1.16), and creatinine change was -0.62 µmol/l (95% CI -3.82 to 2.57 µmol/l).
- The authors conclude that current HES solutions do not provoke renal injury in surgical patients, and trial sequential analysis supported noninferiority for creatinine change.
- Systematic review and meta-analysis of five randomized controlled trials, including 646 adults undergoing brain surgery, with searches run through April 2025.
- Evaluated perioperative dexmedetomidine, given as a loading dose followed by a maintenance infusion, for preventing postoperative delirium.
- The pooled risk ratio was 0.47 (95% CI 0.35-0.63; p < 0.00001), a 53% reduction in delirium risk, with no heterogeneity (I2 = 0%).
- Subgroups showed similar effects across brain tumor and other cranial procedures, adverse events were comparable and mostly mild, and the authors call for multicenter trials.
- Systematic review and meta-analysis of 25 studies including 116,815 surgical patients, with 12 RCTs (n = 845) in the primary analysis.
- Compared perioperative intravenous methadone with other opioids, with respiratory depression defined as naloxone use, respiratory rate under 8/min, or SpO2 under 90%.
- Respiratory depression occurred in 7.7% of methadone patients versus 6.6% of controls, RR 1.22 (95% CI 0.76-1.95), which was not significant.
- The authors found no higher risk with methadone, but rated certainty of evidence as very low, and most data came from retrospective datasets.
- Systematic review and meta-analysis of 20 studies including 19,918 patients undergoing lung resection surgery.
- Evaluated goal-directed fluid therapy as a preventive strategy and linked acute kidney injury to postoperative outcomes.
- Pooled AKI incidence was 5.31% (95% CI, 3.61%-6.70%); AKI was tied to longer stay (MD 0.92 days; 95% CI, 0.52-1.30) and short-term mortality (RR 5.60; 95% CI, 1.66-18.83).
- Goal-directed fluid therapy did not significantly reduce AKI risk (RR 0.64; 95% CI, 0.32-1.27), and the authors call AKI a prognostic indicator warranting early risk stratification.
- Systematic review and meta-analysis of 8 ICU studies with 601 ECMO patients (venovenous and venoarterial) from multiple international centers.
- Compared conservative heparin anticoagulation (aPTT 40-60 seconds, or none) with standard heparin (aPTT 60-80 seconds).
- Major bleeding was lower with conservative strategies (29.5% vs 52.9%; OR 0.40, 95% CI 0.18-0.91; p = 0.03; I² = 72%), while mortality was similar (OR 1.04, 95% CI 0.53-2.05).
- Authors describe a potential association with fewer bleeding events and no clear increase in mortality or thrombotic complications, but caution that null findings do not establish equivalence.
- Umbrella review pooling 7 meta-analyses, 2 systematic reviews, 26 randomised trials and 15 observational studies on induction drugs for general anaesthesia at caesarean delivery.
- Compared drug classes used at induction: opioids, hypnotics (propofol versus thiopental), pressor-response attenuators, and neuromuscular blockers (rocuronium versus suxamethonium).
- Moderate-quality evidence suggested short-acting opioids gave maternal haemodynamic benefit without negative neonatal consequences, and rocuronium at ≥1 mg/kg gave intubation conditions comparable to suxamethonium.
- Authors concluded propofol is a preferred induction agent and rocuronium a suitable alternative to suxamethonium, though low-quality evidence supported propofol's lower risk of maternal accidental awareness.
- Systematic review and meta-analysis of 50 studies comparing minimally invasive pulse wave analysis devices against reference cardiac output techniques.
- Devices were pooled across types and settings, with subgroup analyses by device, clinical setting, and declared conflict of interest.
- Pooled bias was 0.09 L/min (95% CI, -0.05 to 0.23), percentage error 48.3%, and four-quadrant concordance 72.6% (95% CI, 67.9-77.4); I² exceeded 95%.
- Subgroups suggested lower percentage error in ICU (~42%) than noncardiac surgery (~55%), and the authors conclude devices are not interchangeable with reference techniques.
- Systematic review and meta-analysis of six RCTs plus observational, volunteer, and case studies on HFNO and gastric insufflation.
- Four RCTs (n = 375) compared HFNO with face-mask ventilation during elective peri-intubation.
- HFNO significantly reduced gastric insufflation (RR 0.32; 95% CI 0.19-0.52; P < .00001; I² = 0%), rated moderate certainty.
- The authors judge HFNO safe regarding gastric insufflation in most elective contexts, with caution at higher flows and in critically ill patients.
- Systematic review and meta-analysis of 21 studies including 5725 surgical patients aged 18 or older, with 11 non-cardiac and 10 cardiac surgery studies, searched to March 2024.
- Pooled preoperative prevalence of impairment was compared across six cognitive domains, and perioperative changes in those domains were examined.
- Preoperative impairment was highest in executive function at 18% (95% CI, 13%-24%), followed by visuospatial function at 16% and attention/working memory/processing speed at 14%.
- Postoperative impairment peaked at 1 week (attention 35%, 95% CI 4%-66%) and fell by 3 months, with some confidence intervals crossing zero.
- Systematic review and meta-analysis of 9 randomized controlled trials with 672 patients undertaking VATS, drawn from 31 identified studies.
- Intravenous lidocaine was compared with control, with bolus and infusion regimens varying across trials.
- Lidocaine did not reduce 24-hour (5 trials, n = 328) or 48-hour (3 trials, n = 242) postoperative morphine use, or pooled movement pain scores.
- Lidocaine significantly reduced postoperative nausea and vomiting across 5 trials (n = 360) with negligible heterogeneity, and the authors judged it safe.
- Systematic review and meta-analysis of 16 randomized controlled trials including 1133 patients undergoing cardiac surgery with cardiopulmonary bypass.
- Compared intraoperative hemoadsorption using sorbent devices during bypass with bypass conducted without hemoadsorption.
- Hemoadsorption significantly reduced acute kidney injury incidence (RR 0.75; 95% CI 0.59-0.96; p = 0.020).
- Renal replacement therapy, mortality and secondary outcomes showed no significant differences, and the authors call for studies on clinical relevance and patient selection.